A new pancreatic cancer pill may be a game changer for patients
While not a cure, the drug nearly doubles patients’ survival time versus chemotherapy
A drug called daraxonrasib can switch off the signal that tells pancreatic cancer cells (shown in this scanning electron microscopy image) to grow.
Anne Weston, EM STP, the Francis Crick Institute / Science Source
This is a human-written story voiced by AI.